Retatrutide Peptide

Research use only · Not FDA/EMA approved · Details

Price check · 13 vendors · 21 Sep 2026

Retatrutide price

No pharmacy sells retatrutide, so there is no pharmacy price. Research vials do have one: on 21 Sep 2026, 4 of 13 US vendors showed a 10 mg price, from $45.49 to $105, or $4.55 to $10.50 per mg.

6 min read5 sources
vendors showed a 10 mg price
4 of 13
vendors showed a 10 mg price
per mg, cheapest to dearest
$4.55–10.50
per mg, cheapest to dearest
FDA or EMA approvals
0
FDA or EMA approvals

Price of a 10 mg vial, 21 Sep 2026

  • Amino Club$45.49 · $4.55/mg
  • Northline Labs$79.99 · $8.00/mg
  • OXpeptides$99 · $9.90/mg
  • American Peptides$105 · $10.50/mg
Figure 1. The 4 vendors of 13 that showed a 10 mg price on their own page on 21 Sep 2026, US dollars, before any coupon. The other 9 hid it or could not be read. Source: vendor pages, full table
Our pickScore 11 / 11
OXpeptides

Retatrutide 10 mg

  • Janoshik tested, September 2026 lots
  • Lot printed on every vial
  • 1-2 day dispatch, tracked, reship
  • Card with 3-D Secure
Visit OXpeptides

Research use only. Not for human or veterinary use. Retatrutide is an investigational compound that has not been approved by the FDA or the EMA for any use. Nothing on this page is medical advice, dosing guidance or an offer to treat any condition. OXpeptides sells to qualified researchers under its terms.

Retatrutide price by vendor: the 10 mg vial

We opened the pages of 13 US research-peptide vendors on 21 Sep 2026 and wrote down the price of the 10 mg vial as each page showed it. 4 showed a price.

The table sorts them from the cheapest, with the price per milligram and the score each vendor got on the eight checks of our where to buy retatrutide comparison.

Amino Club
10 mg vial
$45.49
Per mg
$4.55
Score / 11
5
What the page showed
Struck from $69.99; 40 % off from 10 units
Northline Labs
10 mg vial
$79.99
Per mg
$8.00
Score / 11
4
What the page showed
Struck from $99.99; free shipping over $250
OXpeptides
10 mg vial
$99
Per mg
$9.90
Score / 11
11
What the page showed
US list price; 5 % and 8 % size discounts
American Peptides
10 mg vial
$105
Per mg
$10.50
Score / 11
4
What the page showed
20 % off the first order

Prices in US dollars as displayed on 21 Sep 2026, before any coupon or bulk discount. Research use only.

The other 9 vendors gave us no price we could write down on 21 Sep 2026. We did not guess one for them:

  • Behind a login or an age gate: Protide Health, Peptira, Simple Peptide, Apex Peptides.
  • Blocked our check: Ion Peptide and Modern Aminos (Cloudflare).
  • No retatrutide page to price: Glow Peptides (page not found), Swiss Chems (no listing), PureRawz (does not sell it).

A login wall or an age gate is not a red flag by itself; it only means the price could not be checked from outside.

Price per milligram: $4.55 to $10.50

The fair way to compare vials is the price per milligram: the vial price divided by the 10 mg on the label. On 21 Sep 2026 that ran from $4.55 at Amino Club to $10.50 at American Peptides, with OXpeptides at $9.90.

All four also list larger vials, and several advertise bulk or first-order discounts. We compare the 10 mg size only, because every priced vendor showed it, and a discount you have to unlock is not the price on the page.

A price per milligram also assumes the vial holds what the label says. That is the weak point, and it is the next section. It also matters beyond the price: a vial at half its label throws off every calculation made from it, including the arithmetic of the retatrutide reconstitution calculator.

Why retatrutide prices vary: the lot, the lab, the paperwork

Two vials at the same price per labelled milligram can be very different products. In 2026, Australian researchers had three products sold as retatrutide analysed; all were labelled 10 mg. They held 5.13 mg, 16.5 mg and 19.0 mg, from 51 to 190 % of the label, and nobody had tested them for sterility or endotoxins[1].

The same pattern shows up with other peptides. In test purchases of semaglutide from online sellers without a prescription, half the orders never arrived, and the vials that did showed 7.7 to 14.4 % purity instead of the 99 % claimed[2].

So the price pays for checks you can verify before paying, or it does not:

  • A certificate per lot that gives the measured content in mg, not only a purity percentage.
  • A named laboratory whose report you can look up.
  • The lot number printed on the vial, matching the certificate.
  • A registered company and tracked shipping.

That is why the cheapest vial is not the best price per milligram you can trust. For reference, the Janoshik report for the OXpeptides 10 mg lot measured 10.59 mg at 99.316 % purity (task 217194, analysed 15 Sep 2026). What the trials recorded at each dose, when the dose is right, is on side effects by dose.

Why there is no pharmacy or insurance price

A pharmacy price exists only for an approved medicine. Retatrutide has no approval from the FDA or the EMA. Eli Lilly, which develops it as LY3437943, plans to file with the FDA in the first quarter of 2027[5]. Until a drug is approved there is no list price, no insurance coverage and no prescription a pharmacy can fill.

Compounding is not a way around it either: section 503A of the FD&C Act limits compounding to approved drugs and to bulk substances on FDA lists, and retatrutide is neither[3].

The only medical route is Lilly's expanded access program, NCT07629401, requested by a physician for adults with a BMI of 35 or more and two serious obesity-related complications[4]. The drug is supplied by Lilly there, not bought.

Everything priced on this page is a research chemical sold for laboratory use, not a treatment. The doses used in the trials, if you want to understand what the studies measured, are on every trial dose, 1 to 12 mg.

Our pick: OXpeptides

On price alone, Amino Club is the cheapest vial we found.

On the checks a buyer can verify before paying, OXpeptides is the only vendor of 13 with all of them: a registered company (OX RESEARCH LTD, no. 17464288), the lot printed on every vial, a public Janoshik report per size, and tracked dispatch in 1 to 2 business days.

It scored 11 of 11; the next vendor scored 5. OXpeptides belongs to OX RESEARCH LTD, which also publishes this site. The full ranking, with every fact and where it was read, is on where to buy retatrutide.

Questions readers ask

How much does retatrutide cost?

There is no pharmacy price, because retatrutide is not approved by the FDA. What has a price is the research-use-only vial. On 21 Sep 2026, 4 of the 13 US vendors we checked showed a price for a 10 mg vial, from $45.49 (Amino Club) to $105 (American Peptides), or $4.55 to $10.50 per mg.

How much is retatrutide per month?

There is no monthly price. Retatrutide is not approved, so there is no prescribed dose to put a monthly cost on, and this site does not turn trial doses into a bill. The doses given in the trials, 1 to 12 mg once a week reached step by step, are listed on the retatrutide dosing schedule.

How much does GLP-3 RT cost?

GLP-3, GLP-3 RT and Reta GLP-3 are shop names for retatrutide. On 21 Sep 2026, Amino Club listed its GLP-3 (RT) 10 mg vial at $45.49 and Northline Labs its Reta GLP-3 10 mg at $79.99. The name changes, the compound and the checks do not.

Is retatrutide covered by insurance?

No. An insurer covers approved medicines, and retatrutide has no approval from the FDA or the EMA. The only lawful routes to the actual drug are a Lilly trial or the expanded access program NCT07629401, where the drug is supplied by Lilly.

Why is one vendor half the price of another?

Because the price pays for different things. The cheapest vial on 21 Sep 2026 scored 5 of 11 on our checks, and the pages of several vendors did not show a company number, a named laboratory or the lot on the vial.

In a 2026 analysis, three vials sold as 10 mg held 5.13, 16.5 and 19.0 mg, so a low price per labelled milligram says little about the milligrams in the glass.

How much will retatrutide cost once it is FDA approved?

Nobody can say yet. A price is set when a drug is approved, and Lilly plans to file with the FDA in the first quarter of 2027. Any figure quoted today for the future medicine is a guess, and we do not repeat one.

Sources

Sources

  1. [1]

    Drug and Alcohol Review · 2026

    Composition and labelling accuracy of products sold as retatrutide in Australia. Drug Alcohol Rev 2026;45(6):e70231.

    Piatkowski T, Craven A, Cornell S, Ferris J

    doi:10.1111/dar.70231
  2. [2]

    JMIR · 2024

    Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription: market surveillance, content analysis, and produc

    Ashraf AR, Mackey TK, Vida RG, et al

    doi:10.2196/65440
  3. [3]

    FDA · 2026

    Human drug compounding: bulk drug substances used in compounding under section 503A of the FD&C Act.

    US Food and Drug Administration

    https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdca
  4. [4]

    ClinicalTrials.gov · 2026

    Pre-approval expanded access of retatrutide (LY3437943).

    Eli Lilly and Company

    https://clinicaltrials.gov/study/NCT07629401